Your browser doesn't support javascript.
loading
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.
Potere, Nicola; Di Nisio, Marcello; Cibelli, Donatella; Scurti, Rosa; Frattari, Antonella; Porreca, Ettore; Abbate, Antonio; Parruti, Giustino.
Afiliação
  • Potere N; Department of Medical, Oral and Biotechnological Sciences, "G D'Annunzio" University, Chieti, Italy.
  • Di Nisio M; VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Cibelli D; Department of Medicine and Ageing Sciences, "G' D'Annunzio" University, Chieti-Pescara, Italy.
  • Scurti R; Department of Vascular Medicine, Amsterdam Medical Center, Amsterdam, The Netherlands.
  • Frattari A; Infectious Diseases Unit, Pescara General Hospital, Pescara, Italy.
  • Porreca E; Geriatric Medicine Unit, Pescara General Hospital, Pescara, Italy.
  • Abbate A; Intensive Care Unit, Pescara General Hospital, Pescara, Italy.
  • Parruti G; Department of Medical, Oral and Biotechnological Sciences, "G D'Annunzio" University, Chieti, Italy.
Ann Rheum Dis ; 80(2): 1-2, 2021 02.
Article em En | MEDLINE | ID: mdl-32647027

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-6 / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-6 / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article